TEST:

BT-Reveal™ Early Pancreatic Cancer Test

The BT-Reveal Early Pancreatic Cancer Test utilizes patented DNA methylation technology that can detect faint tumor DNA signatures in the blood, even at extremely low concentrations. This means the test can catch early stages of pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) when symptoms may not yet be present and while the cancer is still able to be successfully treated through surgery or other techniques)